256 results on '"Di Ianni, Mauro"'
Search Results
2. Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial
3. Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party
4. The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein
5. Correction: Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party
6. Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial.
7. Myelofibrosis and allogeneic transplantation: critical points and challenges.
8. GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL
9. NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models
10. Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia
11. Allogeneic stem cell transplantation in multiple myeloma: is there still a place?
12. Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses.
13. Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics.
14. Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation.
15. Clinical-Grade–Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell–Dependent Graft-versus-Leukemia Effect in Murine Models
16. Daratumumab‐based induction and autologous transplantation in concomitant multiple myeloma and chronic myeloid leukemia.
17. Case Report: Invasive fungal infection after anti-CD19 CAR-T cell therapy. Implication for antifungal prophylaxis.
18. Novel Approaches to Treatment of Acute Myeloid Leukemia Relapse Post Allogeneic Stem Cell Transplantation.
19. Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia.
20. IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation
21. Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT
22. “Designed” grafts for HLA-haploidentical stem cell transplantation
23. Fatigue as Mediator Factor in PTSD-Symptoms after Allogeneic Hematopoietic Stem Cell Transplantation.
24. Dosing Pattern of Ruxolitinib (RUX) in Patients with Myelofibrosis (MF) in Italy: Results from a Prospective Observational Study (ROMEI)
25. T regulatory cell separation for clinical application
26. CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy.
27. Comparison between peripheral blood progenitor cell collection on the 4th or 5th day of granulocyte colony-stimulating factor treatment in allogeneic stem cell donors: implications for hematopoietic progenitor cell apheresis guidelines.
28. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
29. Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation
30. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity
31. CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice
32. Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL
33. The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells
34. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells
35. NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion
36. Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35
37. Large-scale generation of human allodepleted anti-3rd party lymphocytes
38. Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy
39. Association of Platelet Thromboxane Inhibition by Low‐Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia.
40. A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia
41. Bepridil exhibits anti‐leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia
42. γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation
43. Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice
44. Interleukin-7–Engineered Mesenchymal Cells: In Vitro Effects on Naive T-Cell Population
45. T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection
46. Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study
47. NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL
48. A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation
49. B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor α
50. Striking response to intrathecal liposomal cytarabine in a patient with meningeal myelomatosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.